Digital Content 
NEWS #PharmaBuzz
23 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/laekna-announces-fda-approval-for-the-phase-iii-clinical-trial-protocol-of-lae002-afuresertib-plus-lae001-for-the-treatment-of-prostate-cancer-302154036.html
06 Sep 2022
// CLINICALTRIALSARENA
https://www.clinicaltrialsarena.com/news/laekna-prostate-cancer-trial/
31 Jul 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/innovent-and-laekna-jointly-announce-first-patient-dosed-with-three-drug-combination-in-a-phase-12-study-for-the-treatment-of-patients-with-solid-tumors-who-were-resistant-to-prior-anti-pd-1pd-l1-therapy-301596506.html
27 May 2022
// CLINICALTRIALSARENA
https://www.clinicaltrialsarena.com/news/laekna-breast-cancer-trial/
26 May 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/laekna-therapeutics-announces-dosing-of-first-patients-in-the-us-and-china-in-phase-ibiii-study-of-afuresertib-in-combination-with-fulvestrant-in-hrher2--breast-cancer-301555843.html
28 Aug 2018
// Amirah Al Idrus FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/novartis-farms-out-rare-disease-drug-to-lifemax-labs
Share 